---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-101689"
form_type: "8-K"
ticker: "BTAI"
cik: "0001720893"
company_name: "BioXcel Therapeutics, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:49:10.753641+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BioXcel receives Nasdaq deficiency notices for bid price and market value; faces delisting risk

## Summary
- On Sep 16, 2024, Nasdaq notified BTAI that bid price closed below $1.00 for 30 consecutive business days.
- Company has until March 17, 2025 to regain compliance; stock must close at $1.00+ for 10 consecutive days.
- On Sep 20, 2024, Nasdaq notified BTAI that market value of listed securities fell below $35M minimum.
- Compliance deadline for market value is March 19, 2025; must meet $35M+ for 10 consecutive days.
- BTAI evaluating options; cannot assure regaining compliance; may be eligible for second 180-day period.

## SEC filing metadata
- accession: 0001104659-24-101689
- form_type: 8-K
- ticker: BTAI
- cik: 0001720893
- company_name: BioXcel Therapeutics, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720893/000110465924101689/0001104659-24-101689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720893/000110465924101689/tm2424352d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-101689
- JSON: https://secwatch.observer/filing/0001104659-24-101689.json
- Plain text: https://secwatch.observer/filing/0001104659-24-101689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.